does medi-cal cover glp-1 drugs The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Medi-Cal Rx Members | State
Description
The US Food and Drug Administration has also approved certain GLP-1 medications to treat obesity

North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026

Originally FDA-approved for type 2 diabetes, several now carry indications for weight management and cardiovascular risk reduction

10.1161/hh1701.095716